We are live on ! Find out more
VMD icon

Viemed Healthcare

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 85.7%
Negative

Neutral
The Motley Fool
3 days ago
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Neutral
Newsfile Corp
1 month ago
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Neutral
Seeking Alpha
1 month ago
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.
Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Neutral
Accesswire
1 month ago
Viemed Healthcare Announces First Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.
Viemed Healthcare Announces First Quarter 2026 Financial Results
Neutral
Accesswire
1 month ago
Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / April 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its First Quarter 2026 Earnings Conference Call on Wednesday, May 6, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=MWjE55eM Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
Neutral
Accesswire
2 months ago
Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced it will present and host one-on-one meetings with investors at Sidoti's Small-Cap Virtual Investor Conference, taking place on March 18-19, 2026. The presentation will begin at 1:45 p.m.
Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Neutral
Newsfile Corp
3 months ago
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025
Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025
Neutral
Seeking Alpha
3 months ago
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Neutral
Accesswire
3 months ago
Viemed Healthcare Announces 2026 Share Repurchase Program
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 4, 2026.
Viemed Healthcare Announces 2026 Share Repurchase Program